These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32219214)

  • 21. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
    Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
    Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caudatan A, an undescribed human kidney-type glutaminase inhibitor with tetracyclic flavan from Ohwia caudata.
    Sun Y; Feng X; Liu X; Qian C; Che X; Cao F; Jin S; Meng D
    Phytochemistry; 2018 Aug; 152():22-28. PubMed ID: 29715600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
    Elgogary A; Xu Q; Poore B; Alt J; Zimmermann SC; Zhao L; Fu J; Chen B; Xia S; Liu Y; Neisser M; Nguyen C; Lee R; Park JK; Reyes J; Hartung T; Rojas C; Rais R; Tsukamoto T; Semenza GL; Hanes J; Slusher BS; Le A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5328-36. PubMed ID: 27559084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
    Masamha CP; Xia Z; Peart N; Collum S; Li W; Wagner EJ; Shyu AB
    RNA; 2016 Jun; 22(6):830-8. PubMed ID: 27095025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.
    Yeh TK; Kuo CC; Lee YZ; Ke YY; Chu KF; Hsu HY; Chang HY; Liu YW; Song JS; Yang CW; Lin LM; Sun M; Wu SH; Kuo PC; Shih C; Chen CT; Tsou LK; Lee SJ
    J Med Chem; 2017 Jul; 60(13):5599-5612. PubMed ID: 28609101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bmcc1s interacts with the phosphate-activated glutaminase in the brain.
    Boulay AC; Burbassi S; Lorenzo HK; Loew D; Ezan P; Giaume C; Cohen-Salmon M
    Biochimie; 2013 Apr; 95(4):799-807. PubMed ID: 23246912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome.
    Treberg JR; Clow KA; Greene KA; Brosnan ME; Brosnan JT
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1219-25. PubMed ID: 20332361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutaminolysis Was Induced by TGF-β1 through PP2Ac Regulated Raf-MEK-ERK Signaling in Endothelial Cells.
    Guo Y; Deng Y; Li X; Ning Y; Lin X; Guo S; Chen M; Han M
    PLoS One; 2016; 11(9):e0162658. PubMed ID: 27612201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
    Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
    Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Development of Small Molecule Glutaminase Inhibitors.
    Song M; Kim SH; Im CY; Hwang HJ
    Curr Top Med Chem; 2018; 18(6):432-443. PubMed ID: 29793408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases.
    Szeliga M; Obara-Michlewska M
    Neurochem Int; 2009; 55(1-3):71-5. PubMed ID: 19428809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.
    Szeliga M; Ćwikła J; Obara-Michlewska M; Cichocki A; Albrecht J
    Exp Mol Pathol; 2016 Feb; 100(1):74-8. PubMed ID: 26581715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted inhibition of glutaminase as a potential new approach for the treatment of
    Sheikh TN; Patwardhan PP; Cremers S; Schwartz GK
    Oncotarget; 2017 Nov; 8(55):94054-94068. PubMed ID: 29212209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
    J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delineation of an in vivo inhibitor for Aspergillus glutamate dehydrogenase.
    Choudhury R; Noor S; Varadarajalu LP; Punekar NS
    Enzyme Microb Technol; 2008 Jan; 42(2):151-9. PubMed ID: 22578865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.
    Abu Aboud O; Habib SL; Trott J; Stewart B; Liang S; Chaudhari AJ; Sutcliffe J; Weiss RH
    Cancer Res; 2017 Dec; 77(23):6746-6758. PubMed ID: 29021138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Gregory MA; Nemkov T; Reisz JA; Zaberezhnyy V; Hansen KC; D'Alessandro A; DeGregori J
    Exp Hematol; 2018 Feb; 58():52-58. PubMed ID: 28947392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Powerful tumor cell growth-inhibiting activity of a synthetic derivative of atractyligenin: involvement of PI3K/Akt pathway and thioredoxin system.
    Cotugno R; Gallotta D; Piaz FD; Apicella I; De Falco S; Rosselli S; Bruno M; Belisario MA
    Biochim Biophys Acta; 2014 Mar; 1840(3):1135-44. PubMed ID: 24321480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.